Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes
Authors:
- 1 November 2018
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 33 (9) , 3001-3007
Abstract
Bariatric surgery has been shown to be a safe and durable intervention for patients struggling with obesity and metabolic syndrome, including hypertension. Buchwald et al. reported hypertension resolution rates in 67.1% and improvement in 78.5% following aggregate bariatric surgery. The laparoscopic sleeve gastrectomy (LSG) is becoming increasingly utilized as a primary bariatric surgery, but lacks long-term outcome data. There are a growing number of studies reporting outcome data beyond 5 years.Keywords
This publication has 18 references indexed in Scilit:
- Five-year results of laparoscopic sleeve gastrectomy for the treatment of severe obesitySurgical Endoscopy, 2016
- Can Sleeve Gastrectomy “Cure” Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 DiabetesAnnals of Surgery, 2016
- Long-Term Results of Laparoscopic Sleeve Gastrectomy for Morbid Obesity: 5 to 8-Year ResultsObesity Surgery, 2016
- Trends in utilization of bariatric surgery, 2009–2012Surgical Endoscopy, 2015
- Long-term Weight and Metabolic Effects of Laparoscopic Sleeve Gastrectomy Calibrated with a 50-Fr BougieObesity Surgery, 2015
- Robotic sleeve gastrectomy for morbid obesity: report of a 5 year experienceThe International Journal of Medical Robotics and Computer Assisted Surgery, 2015
- Efficacy of sleeve gastrectomy as sole procedure in patients with clinically severe obesity (BMI ≤50 kg/m2)Surgery for Obesity and Related Diseases, 2013
- Laparoscopic Sleeve Gastrectomy for Morbid Obesity: 5 Years Experience from an Asian Center of ExcellenceObesity Surgery, 2013
- Sleeve gastrectomy: 5-year outcomes of a single institutionSurgery for Obesity and Related Diseases, 2013
- Bariatric SurgeryJAMA, 2004